Novel prophylactic and/or therapeutic agent for diabetic neuropathy

Details for Australian Patent Application No. 2008225379 (hide)

Owner Astellas Pharma Inc.

Inventors Aoki, Toshiaki; Hamakawa, Nozomu; Yamamoto, Hiroko; Tamura, Seiji; Murai, Nobuhito

Agent Davies Collison Cave

Pub. Number AU-A-2008225379

PCT Pub. Number WO2008/111669

Priority 2007-242210 19.09.07 JP; 2007-066727 15.03.07 JP

Filing date 14 March 2008

Wipo publication date 18 September 2008

International Classifications

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 September 2009 PCT application entered the National Phase

  PCT publication WO2008/111669 Priority application(s): WO2008/111669

12 November 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Novel preventive and/or therapeutic agent for diabetic neuropathy

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008225398-Mg-based alloy plated steel material

2008225378-Novel prophylactic and/or therapeutic agent for neurogenic pain